SBIR/STTR Research Award
Freyja Healthcare: O-scope
Award amount
$49,950Program and phase
SBIR · Phase IAward year
2022Award details
- Awarding agency
- Department of Defense
- Branch
- Air Force
- Recipient company
- FREYJA HEALTHCARE, LLC
- Proposal award date
- 2021-10-29
- Contract end date
- 2022-02-07
- UEI
- V5F5W6R67JE1
- Solicitation number
- X21.2
- Topic code
- AF212-CSO1
Research abstract
Ovarian cancer ranks fifth in cancer deaths among women, accounting for more deaths than any other cancer of the female reproductive system. A woman's risk of getting ovarian cancer during her lifetime is about 1 in 78. Her lifetime chance of dying from o
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Deployable Abdominal Imaging: Real-Time Diagnostics for Combat Zones
- O-ScopeTM - Non-surgical, least-Invasive Diagnostic and Screening for Ovarian Cancer and Endometriosis
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Monitoring Evolution of Coordinated Inauthentic Behavior
- Automated Target Recognition for Rapid Multitarget Grouping, Discrimination and Neutralization
- Composite Binder Enabling Higher Propellant Loading and Performance for Extended Range and Reduced Mass Missile Propulsion
- Video Based Assessment Capabilities and Human Performance Optimization
- Secure, BYOAD Enterprise Talk, Text, Video, and Data Transmission for Air Force Special Operations Command in Communications Denied/Degraded Environments
Research funding history
3 SBIR/STTR records share this UEI (2022–2025). Reported award amounts total $874,488. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Defense